New tools for the quantitative assessment of prodrug delivery and neurotoxicity.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Neurotoxicology

• Publication date

  2015-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.neuro.2015.02.005PMID 25732874PMCID PMC4501381
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Modeling Survival Data Extending The Cox Model

  2016influential reference
• Image-Guided Tumor Resection

  2015cited by this paper
• The paradox of paclitaxel neurotoxicity: Mechanisms and unanswered questions.

  2014cited by this paper
• R: A language and environment for statistical computing.

  2014cited by this paper
• Prodrugs: A challenge for the drug development

  2013influential reference
• Synthesis and in vitro efficacy of MMP9-activated NanoDendrons.

  2013cited by this paper
• Defining Risks of Taxane Neuropathy: Insights from Randomized Clinical Trials

  2013cited by this paper
• Inhibition of mammary tumor growth using lysyl oxidase-targeting nanoparticles to modify extracellular matrix.

  2012cited by this paper
• A docetaxel-carboxymethylcellulose nanoparticle outperforms the approved taxane nanoformulation, Abraxane, in mouse tumor models with significant control of metastases.

  2012influential reference
• Detection of MMP-2 and MMP-9 activity in vivo with a triple-helical peptide optical probe.

  2012cited by this paper
• Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention.

  2012influential reference
• Theranostic applications of nanoparticles in cancer.

  2012cited by this paper
• Chemotherapy-induced peripheral neurotoxicity (CIPN): an update.

  2012influential reference
• Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications

  2012cited by this paper
• Rapid response activatable molecular probes for intraoperative optical image‐guided tumor resection

  2012cited by this paper
• Chemotherapy‐Induced Peripheral Neuropathy: Prevention and Treatment

  2011cited by this paper
• Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics.

  2011influential reference
• Chemotherapy‐induced peripheral neurotoxicity can be misdiagnosed by the National Cancer Institute Common Toxicity scale

  2011cited by this paper
• Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice

  2011cited by this paper
• Longitudinal live animal micro-CT allows for quantitative analysis of tumor-induced bone destruction.

  2011cited by this paper
• Theranostics: combining imaging and therapy.

  2011cited by this paper
• Near-infrared optical proteolytic beacons for in vivo imaging of matrix metalloproteinase activity.

  2010cited by this paper
• High-performance nanostructured MR contrast probes.

  2010cited by this paper
• Monitoring of MMPs activity in vivo, non-invasively, using solubility switchable MRI contrast agent.

  2009cited by this paper
• Optical proteolytic beacons for in vivo detection of matrix metalloproteinase activity.

  2009cited by this paper
• Nanoparticle therapeutics: an emerging treatment modality for cancer

  2008cited by this paper
• Imaging matrix metalloproteinases in cancer

  2008cited by this paper
• Peripheral nerve damage associated with administration of taxanes in patients with cancer.

  2008cited by this paper
• Novel solubility‐switchable MRI agent allows the noninvasive detection of matrix metalloproteinase‐2 activity in vivo in a mouse model

  2008cited by this paper
• Inflammation and breast cancer. Metalloproteinases as common effectors of inflammation and extracellular matrix breakdown in breast cancer

  2008cited by this paper
• Effect of ablation or inhibition of stromal matrix metalloproteinase-9 on lung metastasis in a breast cancer model is dependent on genetic background.

  2008cited by this paper
• Establishment and quantitative imaging of a 3D lung organotypic model of mammary tumor outgrowth

  2008cited by this paper
• Optical Imaging of Matrix Metalloproteinase-7 Activity in Vivo Using a Proteolytic Nanobeacon

  2008cited by this paper
• The other side of MMPs: Protective roles in tumor progression

  2007cited by this paper
• Noninvasive Detection of Matrix Metalloproteinase Activity In Vivo using a Novel Magnetic Resonance Imaging Contrast Agent with a Solubility Switch

  2007cited by this paper
• PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality.

  2006cited by this paper
• The future of breast cancer: the role of prognostic factors

  2005cited by this paper
• Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer.

  2005influential reference
• The R Package geepack for Generalized Estimating Equations

  2005cited by this paper
• Estimating equations for association structures

  2004cited by this paper
• Proteinase Activity in Human and Murine Saliva as a Biomarker for Proteinase Inhibitor Efficacy

  2004cited by this paper
• Development of a novel fluorogenic proteolytic beacon for in vivo detection and imaging of tumour-associated matrix metalloproteinase-7 activity.

  2004cited by this paper
• Molecular imaging of proteolytic activity in cancer

  2003cited by this paper
• A Residue in the S2 Subsite Controls Substrate Selectivity of Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9*

  2003cited by this paper
• Molecular imaging of MMP expression and therapeutic MMP inhibition.

  2002cited by this paper
• Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations

  2002cited by this paper
• MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis.

  2002cited by this paper
• Fibroblasts promote breast cancer cell invasion by upregulating tumor matrix metalloproteinase-9 production.

  2002cited by this paper
• The organ microenvironment and cancer metastasis.

  2002cited by this paper
• Rapid and Efficient Synthesis of Aliphatic Ester Dendrons and Dendrimers

  2002cited by this paper
• Substrate Hydrolysis by Matrix Metalloproteinase-9*

  2001cited by this paper
• MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis.

  2000cited by this paper
• MMP-9 Supplied by Bone Marrow – Derived Cells Contributes to Skin Carcinogenesis

  2000cited by this paper
• Cancer biology: extracellular proteinases in malignancy.

  1999cited by this paper
• Metastatic potential correlates with enzymatic degradation of basement membrane collagen

  1980cited by this paper

• Fn14-Directed DART Nanoparticles Selectively Target Neoplastic Cells in Preclinical Models of Triple-Negative Breast Cancer Brain Metastasis.

  2022cites this paper
• Effectiveness and Tolerability of Nab-paclitaxel in Younger versus Elderly Patients With Metastatic HR-positive/HER2-negative Breast Cancer: Results From the Noninterventional, Prospective Study NABUCCO.

  2020cites this paper
• Secreted Matrix Metalloproteinase-9 of Proliferating Smooth Muscle Cells as a Trigger for Drug Release from Stent Surface Polymers in Coronary Arteries.

  2016cites this paper